Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$36.01 - $86.53
Next Earnings Date
May 12 2025
Next Earnings Date
May 12 2025
Latest price
Market Cap | $1.87B |
EV | $1.73B |
Shares Outstanding | 35.52M |
Beta | -1.52 |
Analyst Rating | BUY |
Analyst Target Price | $85.00 |
P/E 2025E | - |
P/Revenue 2025E | 187.21x |
Revenue | - |
EPS | -5.30% |
Operating Cash Flow | -57.60% |
Free Cash Flow | -49.50% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | -55.00% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -367.12% |
ROE 2025E | - |
ROCE 2024 | -30.60% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Belite Bio, Inc
BLTE
Sector
Healthcare
Industry
Biotechnology
CEO
Lin, Yu-Hsin
Employees
25
Website
www.belitebio.comIPO Date
2022-04-29
Headquarters
12750 High Bluff Drive, Suite 475, San Diego, California, 92130, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved